Elsevier’s Oncology Journal Network highlights

Cancer Letters

• ●

  High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcomaopens in new tab/window

• ●

  Noncanonical roles of p53 in cancer stemness and their implications in sarcomasopens in new tab/window

• ●

  Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcomaopens in new tab/window

We’ll help you find the right home for your research – fast

With over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper.

Article Advance

Your paper, our priority

Article Advance ensures a fast, seamless publication process and offers additional support from a dedicated editorial team.